VISEN PHARMA-B (02561) Results Announcements
| Date | Type | Title | Filing |
|---|---|---|---|
| 2026-08-27 | Interim Results | (1) INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026; (2) RESIGNATION OF DIRECTOR; AND (3) CHANGE OF COMPOSITION OF THE BOARD COMMITTEES | |
| 2026-08-17 | Board Meeting Date | DATE OF BOARD MEETING | |
| 2026-03-12 | Final Results | ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025 | |
| 2026-03-02 | Board Meeting Date | DATE OF BOARD MEETING | |
| 2025-08-27 | Interim Results | (1) INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MOTNHS ENDED JUNE 30, 2025; (2) RESIGNATION OF NON-EXECUTIVE DIRECTOR AND APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR; AND (3) CHANGE IN COMPOSITION OF THE AUDIT COMMITTEE | |
| 2025-08-15 | Board Meeting Date | DATE OF BOARD MEETING | |
| 2025-03-27 | Final Results | FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2024 |
Sourced from HKEXnews. Hong Kong does not mandate quarterly reporting — most issuers file interim and final results only. Profit warnings and board meeting dates are included as pre-results signals.